Skip to main content
ZheJiang Tailin Bioengineering Co.,Ltd logo

ZheJiang Tailin Bioengineering Co.,Ltd — Investor Relations & Filings

Ticker · 300813 ISIN · CNE100003S89 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,000 across all filing types
Latest filing 2024-04-23 Investor Presentation
Country CN China
Listing Shenzhen Stock Exchange 300813

About ZheJiang Tailin Bioengineering Co.,Ltd

https://www.tailingood.com

ZheJiang Tailin Bioengineering Co.,Ltd. specializes in the research, development, and manufacturing of high-tech equipment for life sciences and pharmaceutical engineering. The company provides integrated solutions for microbial control, sterility testing, and aseptic processing. Its core product portfolio includes sterility test canisters and pumps, microbial limit testing systems, and hydrogen peroxide vapor (VHP) decontamination units. Tailin also develops advanced isolator technology for containment and aseptic applications, alongside analytical instruments such as Total Organic Carbon (TOC) analyzers and filter integrity testers. These products are designed to meet international regulatory standards, including GMP, USP, and EP. The company serves sectors such as biopharmaceuticals, medical devices, and laboratory research, focusing on product safety and quality through specialized engineering and microbial detection technologies.

Recent filings

Filing Released Lang Actions
关于召开2023年度网上业绩说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement about the scheduling and details of the 2023 annual performance explanation meeting (业绩说明会) to be held online. It invites investors to participate and submit questions in advance. The document does not contain actual financial data or detailed financial results, but rather serves as a notice for an upcoming event where such information will be discussed. The document length is short (701 characters), and it is clearly an announcement rather than a report or transcript. Therefore, it fits best into the category of Investor Presentation (IP), as it relates to a presentation event focused on financial performance and investor communication.
2024-04-23 Chinese
关于召开2023年年度股东大会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2023 Annual General Meeting (AGM) of Zhejiang Tailin Biotechnology Co., Ltd. It includes information about the meeting time, location, agenda items (such as approval of the 2023 annual report, board reports, profit distribution, election of directors, and other shareholder proposals), voting procedures (including onsite and online voting), and registration details. The document also contains attachments like proxy forms and shareholder registration forms. It does not contain the actual annual report or financial statements but rather the notification and procedural details for the AGM. Therefore, this document fits the category of AGM Information (AGM-R).
2024-04-23 Chinese
长城证券股份有限公司关于浙江泰林生物技术股份有限公司使用部分闲置募集资金及自有资金进行现金管理的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from Great Wall Securities Co., Ltd. regarding Zhejiang Tailin Biotechnology Co., Ltd.'s use of idle raised funds and own funds for cash management. It includes extensive information about the company's fundraising activities, approvals by the board and supervisory committee, investment purposes, risk control measures, and compliance with regulatory requirements. The document is not a full annual or interim financial report, nor is it a simple announcement. It is a formal audit or verification report related to the use of raised funds, which aligns with the definition of an Audit Report / Information (AR). The document length (6879 characters) and content confirm it is a substantive report rather than a brief announcement or certification. Therefore, the appropriate classification is AR with high confidence. FY 2024
2024-04-23 Chinese
独立董事2023年度述职报告（李继承）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2023 Annual Work Report" for Zhejiang Tailin Biotechnology Co., Ltd. It details the independent director's activities, attendance at board meetings, committee work, communication with auditors, and oversight of company governance and shareholder interests during the year 2023. The content is a detailed report of the independent director's duties and performance over the year, not an announcement or a brief summary. It does not contain financial statements or audit opinions but focuses on governance and director responsibilities. This fits the category of Board/Management Information (MANG), which includes announcements or reports related to board members and senior management activities. The document length is 2856 characters, which is relatively short but contains substantive content about the director's work rather than just an announcement of a report. Therefore, the best classification is MANG with high confidence.
2024-04-23 Chinese
独立董事提名人声明与承诺（杨忠智）
Board/Management Information Classification · 95% confidence The document is a formal statement and commitment from the nominating party regarding the nomination of an independent director candidate for the company's board. It details qualifications, compliance with laws and regulations, and declarations about the nominee's independence and eligibility. There is no financial data, no report of financial performance, no voting results, no management changes announcement, and no mention of shareholder votes or meeting materials. The document is a nomination statement related to board composition but does not announce a change or appointment itself. It is not a proxy solicitation or voting results announcement. It is a regulatory disclosure related to board/management information but specifically about nomination and compliance statements for an independent director candidate. This fits best under Board/Management Information (MANG) as it concerns board-related disclosures about director nominations and qualifications.
2024-04-23 Chinese
关于续聘天健会计师事务所（特殊普通合伙）为2024年度审计机构的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the reappointment of an audit firm (Tianjian Accounting Firm) as the auditor for the fiscal year 2024. It details the qualifications, independence, and past performance of the audit firm, as well as the approval process by the board, audit committee, and supervisory board. The document does not contain any actual audit report or financial statements but is a formal announcement of the intention to reappoint the auditor, pending shareholder approval at the 2023 annual general meeting. The document length is 3292 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this document fits best under the category of Audit Report / Information (AR) as it relates specifically to audit matters and the appointment of the audit firm, but it is not a full annual report or audit report itself. However, since it is an announcement about the audit firm appointment and not the audit report itself, it is more appropriate to classify it as Regulatory Filings (RNS) because it is a regulatory announcement about audit firm appointment rather than the audit report or audit results themselves.
2024-04-23 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.